Evaluation of inactivated infectious bovine rhinotracheitis vaccines.

Abstract

Sixty-five calves of approximately three months of age and of mixed sex were vaccinated twice at four week intervals with either attenuated or inactivated infectious bovine rhinotracheitis vaccines. Following initial vaccination there was no demonstrable serum infectious bovine rhinotracheitis titer in any of the calves receiving the inactivated vaccine with 20.7% of the calves receiving the attenuated vaccines having demonstrable titers. Following a second administration of vaccine at eight weeks post-initial vaccination 63.9% of the calves receiving the inactivated vaccine had no demonstrable titer with 72.4% of the calves receiving the attenuated vaccine exhibiting a blood titer of four or greater.

• Authors: I A Schipper, C L Kelling
• Journal: Canadian journal of comparative medicine : Revue canadienne de medecine comparee (Can J Comp Med) Vol. 39 Issue 4 Pg. 402-5 (Oct 1975) ISSN: 0008-4050 [Print] Canada
• PMID: 169968 (Publication Type: Journal Article)

Chemical References

• Vaccines, Attenuated
• Viral Vaccines

Topics

• Animals
• Cattle (immunology)
• Evaluation Studies as Topic
• Female
• Herpesvirus 1, Bovine (immunology)
• Infectious Bovine Rhinotracheitis (therapy)
• Male
• Nasal Mucosa (metabolism)
• Tears (metabolism)
• Vaccines, Attenuated (administration & dosage, adverse effects)
• Viral Vaccines (administration & dosage, adverse effects)